Journal of Correctional Health Care - April 2023 - 106

106
TAMBURELLO ET AL.
Goldstein, B. I., Birmaher, B., Carlson, G. A., DelBello, M. P., Findling, R. L.,
Fristad, M., Kowatch, R. A., Miklowitz, D. J., Nery, F. G., Perez-Algorta, G.,
Van Meter, A., Zeni, C. P., Correll, C. U., Kim, H. W., Wozniak, J., Chang, K. D.,
Hillegers, M., & Youngstrom, E. A. (2017). The International Society for
Bipolar Disorders Task Force report on pediatric bipolar disorder:
Knowledge to date and directions for future research. Bipolar Disorders,
19(7), 524-543. https://doi.org/10.1111/bdi.12556
Gorman, D. A., Gardner, D. M., Murphy, A. L., Feldman, M., Be´langer, S. A.,
Steele, M. M., Boylan, K., Cochrane-Brink, K., Goldade, R., Soper, P. R.,
Ustina, J., & Pringsheim, T. (2015). Canadian guidelines on pharmacotherapy
for disruptive and aggressive behaviour in children and adolescents
with attention-deficit hyperactivity disorder, oppositional
defiant disorder, or conduct disorder. Canadian Journal of Psychiatry,
60(2), 62-76. https://doi.org/10.1177/070674371506000204
Haapasalo-Pesu, K. M., Vuola, T., Lahelma, L., & Marttunen, M. (2004). Mirtazapine
in the treatment of adolescents with major depression: An
open-label, multicenter pilot study. Journal of Child and Adolescent Psychopharmacology,
14(2), 175-184. https://doi.org/10.1089/
1044546041649110
Hambly, J. L., Khan, S., McDermott, B., Bor, W., & Haywood, A. (2016).
Pharmacotherapy of conduct disorder: Challenges, options and future
directions. Journal of Psychopharmacology, 30(10), 967-975. https://doi
.org/10.1177/0269881116658985
Harzke, A. J., Baillargeon, J., Baillargeon, G., Henry, J., Olvera, R. L., Torrealday,
O., Penn, J. V., & Parikh, R. (2012). Prevalence of psychiatric disorders in
the Texas juvenile correctional system. Journal of Correctional Health
Care, 18(2), 143-157. https://doi.org/10.1177/1078345811436000
Harzke, A. J., Baillargeon, J., Baillargeon, G., Olvera, R., Torrealday, O., Penn, J.
V., & Parikh, R. (2011). Co-occurrence of substance use disorders with
other psychiatric disorders in the Texas juvenile correctional system.
International Journal of Prisoner Health, 7(2-3), 4-15.
Hawkins, J. D., Herrenkohl, T. I., Farrington, D. P., Brewer, D., Catalano, R. F.,
Harachi, T. W., & Cothern, L. (2000). Predictors of youth violence (NCJ
179065). Juvenile Justice Bulletin. https://www.ojp.gov/pdffiles1/ojjdp/
179065.pdf
Hawton, K., Saunders, K. E., & O'Connor, R. C. (2012). Self-harm and suicide in
adolescents. Lancet, 379(9834), 2373-2382. https://doi.org/10.1016/
S0140-6736(12)60322-5
Institute for Safe Medication Practices. (2020, February 21). Oral dosage
forms that should not be crushed [Recommendations]. https://www.ismp
.org/recommendations/do-not-crush
Jaffer, K. Y., Chang, T., Vanle, B., Dang, J., Steiner, A. J., Loera, N., Abdelmesseh,
M., Danovitch, I., & Ishak, W. W. (2017). Trazodone for insomnia: A
systematic review. Innovations in Clinical Neuroscience, 14(7-8), 24-34.
https://www.ncbi.nlm.nih.gov/pubmed/29552421
Jensen-Doss, A., Douglas, S., Phillips, D. A., Gencdur, O., Zalman, A., & Gomez,
N. E. (2020). Measurement-based care as a practice improvement tool:
Clinical and organizational applications in youth mental health. EvidenceBased
Practice in Child and Adolescent Mental Health, 5(3), 233-250.
https://doi.org/10.1080/23794925.2020.1784062
Juvenile Justice Delinquency and Prevention Act. (1974). x Public Law 93-
415, 88 Stat. 1109.
Kaliebe, K. E., Heneghan, J., & Kim, T. J. (2011). Telepsychiatry in juvenile
justice settings. Child and Adolescent Psychiatric Clinics of North America,
20(1), 113-123. https://doi.org/10.1016/j.chc.2010.09.001
Kasinathan, J. (2015). Predictors of rapid reincarceration in mentally ill
young offenders. Australasian Psychiatry, 23(5), 550-555. https://doi.org/
10.1177/1039856215597532
Kawabe, K., Horiuchi, F., Oka, Y., & Ueno, S. (2014). The melatonin receptor
agonist ramelteon effectively treats insomnia and behavioral symptoms
in autistic disorder. Case Reports in Psychiatry, 2014, 561071. https://doi
.org/10.1155/2014/561071
Kerwin, M. E., Kirby, K. C., Speziali, D., Duggan, M., Mellitz, C., Versek, B., &
McNamara, A. (2015). What can parents do? A review of state laws regarding
decision making for adolescent drug abuse and mental health
treatment. Journal of Child & Adolescent Substance Abuse, 24(3), 166-176.
https://doi.org/10.1080/1067828X.2013.777380
Krakowski, M., Tural, U., & Czobor, P. (2021). The importance of conduct
disorder in the treatment of violence in schizophrenia: Efficacy of clozapine
compared with olanzapine and haloperidol. American Journal of
Psychiatry, 178(3), 266-274. https://doi.org/10.1176/appi.ajp.2020
.20010052
LeClerc, S., & Easley, D. (2015). Pharmacological therapies for autism spectrum
disorder: A review. P & TPharmacy and Therapeutics, 40(6), 389-397.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450669/
Lee, T. G., Walker, S. C., & Bishop, A. S. (2016). The impact of psychiatric
practice guidelines on medication costs and youth aggression in a juvenile
justice residential treatment program. Psychiatric Services, 67(2),
214-220. https://doi.org/10.1176/appi.ps.201400544
Linares-Orama, N. (2005). Language-learning disorders and youth incarceration.
Journal of Communication Disorders, 38(4), 311-319. https://doi
.org/10.1016/j.jcomdis.2005.02.006
Lunsford-Avery, J. R., Bidopia, T., Jackson, L., & Sloan, J. S. (2021). Behavioral
treatment of insomnia and sleep disturbances in school-aged children
and adolescents. Child and Adolescent Psychiatric Clinics ofNorth America,
30(1), 101-116. https://doi.org/10.1016/j.chc.2020.08.006
Lyons,C. L.,Wasserman, G.A.,Olfson,M.,McReynolds,L.S.,Musabegovic,H.,&
Keating, J. M. (2013). Psychotropic medication patterns among youth in
juvenilejustice. Administration and Policy in Mental Health and Mental Health
Services Research, 40(2), 58-68. https://doi.org/10.1007/s10488-011-0378-4
Mallett, C. A. (2014). Youthful offending and delinquency: The comorbid
impact of maltreatment, mental health problems, and learning disabilities.
Child and Adolescent Social Work Journal, 31(4), 369-392. https://
doi.org/10.1007/s10560-013-0323-3
Malmgren, K., Abbott, R. D., & Hawkins, J. D. (1999). LD and delinquency:
Rethinking the ''link.'' Journal of Learning Disabilities, 32(3), 194-200.
https://doi.org/10.1177/002221949903200301
March, J. S., Silva, S., Petrycki, S., Curry, J., Wells, K., Fairbank, J., Burns, B.,
Domino, M., McNulty, S., Vitiello, B., & Severe, J. (2007). The Treatment for
Adolescents With Depression Study (TADS): Long-term effectiveness and
safety outcomes. Archives of General Psychiatry, 64(10), 1132-1143.
https://doi.org/10.1001/archpsyc.64.10.1132
Margolin, G., & Vickerman, K. A. (2007). Post-traumatic stress in children and
adolescents exposed to family violence: I. Overview and issues. Professional
Psychology: Research and Practice, 38(6), 613-619. https://doi
.org/10.1037/0735-7028.38.6.613
Mayer, G. R. (2001). Antisocial behavior: Its causes and prevention within our
schools. Education and Treatment of Children, 24(4), 414-429.
McClellan, J., Kowatch, R., Findling, R. L., & the Work Group on Quality Issues.
(2007). Practice parameter for the assessment and treatment of children
and adolescents with bipolar disorder [AACAP official action]. Journal of
the American Academy of Child and Adolescent Psychiatry, 46(1), 107-125.
https://doi.org/10.1097/01.chi.0000242240.69678.c4
McKee, J., Penn, J. V., & Koranek, A. (2014). Psychoactive medication misadventuring
in correctional health care. Journal of Correctional Health
Care, 20(3), 249-260. https://doi.org/10.1177/1078345814532419
Miller, W. R., & Brown, J. M. (1994). What I want from treatment (2.0). Center
on Alcohol, Substance Use, and Addictions. https://casaa.unm.edu/inst/
What%20I%20Want%20From%20Treatment.pdf
Moffitt, T. E. (1993). Adolescence-limited and life-course-persistent antisocial
behavior: A developmental taxonomy. Psychological Review, 100(4),
674-701. https://doi.org/10.1037/0033-295X.100.4.674
Moffitt, T. E. (2018). Male antisocial behaviour in adolescence and beyond.
Nature Human Behaviour, 2, 177-186. https://doi.org/10.1038/s41562018-0309-4
Mohammadpour,
N., Jazayeri, S., Tehrani-Doost, M., Djalali, M., Hosseini, M.,
Effatpanah, M., Davari-Ashtiani, R., & Karami, E. (2018). Effect of vitamin D
supplementation as adjunctive therapy to methylphenidate on ADHD
symptoms: A randomized, double blind, placebo-controlled trial. Nutritional
Neuroscience, 21(3), 202-209. https://doi.org/10.1080/1028415X
.2016.1262097
Moran, L. V., Ongur, D., Hsu, J., Castro, V. M., Perlis, R. H., & Schneeweiss, S.
(2019). Psychosis with methylphenidate or amphetamine in patients with
ADHD. New England Journal of Medicine, 380(12), 1128-1138. https://doi
.org/10.1056/NEJMoa1813751
Morris, K. A., & Morris, R. J. (2006). Disability and juvenile delinquency: Issues
and trends. Disability & Society, 21(6), 613-627. https://doi.org/10.1080/
09687590600918339
National Commission on Correctional Health Care. (2015). Standards for health
services in juvenile detention and confinement facilities.Chicago:NCCHC.
National Commission on Correctional Health Care. (2021). Use of humanizing
language in correctional health care [Position statement]. https://www
.ncchc.org/wp-content/uploads/Use-of-Humanizing-Language-inCorrectional-Health-Care-2021.pdf
National
Institute for Health and Care Excellence. (2017). Antisocial behaviour
and conduct disorders in children and young people [Clinical guideline
CG158]. https://www.nice.org.uk/guidance/cg158
National Institute for Health and Care Excellence. (2020). Bipolar disorder:
Assessment and management [Clinical guideline CG185]. http://www.nice
.org.uk/guidance/cg185
Journal of Correctional Health Care - April 2023

Table of Contents for the Digital Edition of Journal of Correctional Health Care - April 2023
